Felix (Drug Discovery) Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Out of Business

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Out of Business

Felix (Drug Discovery) General Information

Description

Developer of programmable therapies designed to protect the world against the threat of antimicrobial resistance. The company's therapies target antibiotic-resistant bacteria to manage infectious diseases precisely and effectively, enabling healthcare professionals to manage urgent microbial challenges in human health.

Contact Information

Website
www.felixbt.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 329 Oyster Point Boulevard
  • 3rd Floor South
  • San Francisco, CA 94080
  • United States
+1 (800)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 329 Oyster Point Boulevard
  • 3rd Floor South
  • San Francisco, CA 94080
  • United States
+1 (800)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Felix (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Out of Business 12-Jul-2024 Completed Out of Business
8. Grant 22-Jul-2022 Completed Clinical Trials - Phase 1
7. Grant 15-Apr-2022 Completed Clinical Trials - Phase 1
6. Grant 02-Mar-2022 Completed Clinical Trials - Phase 1
5. Grant 01-Sep-2021 Completed Clinical Trials - Phase 1
4. Seed Round Completed Clinical Trials - Phase 1
3. Seed Round 17-Mar-2020 Completed Clinical Trials - Phase 1
2. Accelerator/Incubator 08-Nov-2019 Completed Clinical Trials - Phase 1
1. Accelerator/Incubator 21-Oct-2019 Completed Clinical Trials - Phase 1
To view Felix (Drug Discovery)’s complete valuation and funding history, request access »

Felix (Drug Discovery) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of programmable therapies designed to protect the world against the threat of antimicrobial resistance. The co
Biotechnology
San Francisco, CA
6 As of 2023

Broomfield, CO
 

Madison, WI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Felix (Drug Discovery) Competitors (38)

One of Felix (Drug Discovery)’s 38 competitors is Cerecin, a Venture Capital-Backed company based in Broomfield, CO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cerecin Venture Capital-Backed Broomfield, CO
Centrose Venture Capital-Backed Madison, WI
Vividion Therapeutics Formerly VC-backed San Diego, CA
Prokaryotics Corporation Union, NJ
Arisan Therapeutics Accelerator/Incubator Backed Carlsbad, CA
You’re viewing 5 of 38 competitors. Get the full list »

Felix (Drug Discovery) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Felix (Drug Discovery) FAQs

  • When was Felix (Drug Discovery) founded?

    Felix (Drug Discovery) was founded in 2019.

  • Where is Felix (Drug Discovery) headquartered?

    Felix (Drug Discovery) is headquartered in San Francisco, CA.

  • What is the size of Felix (Drug Discovery)?

    Felix (Drug Discovery) has 6 total employees.

  • What industry is Felix (Drug Discovery) in?

    Felix (Drug Discovery)’s primary industry is Biotechnology.

  • Is Felix (Drug Discovery) a private or public company?

    Felix (Drug Discovery) is a Private company.

  • What is Felix (Drug Discovery)’s current revenue?

    The current revenue for Felix (Drug Discovery) is .

  • How much funding has Felix (Drug Discovery) raised over time?

    Felix (Drug Discovery) has raised $150K.

  • Who are Felix (Drug Discovery)’s competitors?

    Cerecin, Centrose, Vividion Therapeutics, Prokaryotics, and Arisan Therapeutics are some of the 38 competitors of Felix (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process